Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 208, doi. 10.1002/pds.3713
- By:
- Publication type:
- Article
Works in Pharmacoepidemiology & Drug Safety, 2015, Vol 24, Issue 2
Results: 15
1
2
Impact of abuse-deterrent OxyContin on prescription opioid utilization.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 197, doi. 10.1002/pds.3723
- By:
- Publication type:
- Article
3
How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 137, doi. 10.1002/pds.3679
- By:
- Publication type:
- Article
4
Increasing use of ADHD medications in pregnancy.
- Published in:
- 2015
- By:
- Publication type:
- Other
5
Post-approval appending of CSARs to drug package inserts: an analysis of the types of adverse reactions and time to addition.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 166, doi. 10.1002/pds.3629
- By:
- Publication type:
- Article
6
Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 121, doi. 10.1002/pds.3654
- By:
- Publication type:
- Article
7
Adverse drug events in patients admitted to an emergency department: an analysis of direct costs.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 176, doi. 10.1002/pds.3663
- By:
- Publication type:
- Article
8
Anticipated and unanticipated consequences of abuse deterrent formulations of opioid analgesics.
- Published in:
- 2015
- By:
- Publication type:
- Other
9
Re-examining antidepressant risk of self-injury in children and adolescents.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 215, doi. 10.1002/pds.3737
- By:
- Publication type:
- Article
10
A cross-national comparison of 17 countries' insulin glargine drug labels.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 159, doi. 10.1002/pds.3704
- By:
- Publication type:
- Article
11
Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 187, doi. 10.1002/pds.3683
- By:
- Publication type:
- Article
12
Antibiotic prescribing by telephone in primary care.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 113, doi. 10.1002/pds.3686
- By:
- Publication type:
- Article
13
Adverse drug reaction reports of patients and healthcare professionals-differences in reported information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 152, doi. 10.1002/pds.3687
- By:
- Publication type:
- Article
14
Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 144, doi. 10.1002/pds.3688
- By:
- Publication type:
- Article
15
Antibiotic therapy for inpatients with community-acquired pneumonia in a developing country.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2015, v. 24, n. 2, p. 129, doi. 10.1002/pds.3614
- By:
- Publication type:
- Article